PubRank

Boro Dropulic

Author PubWeight™ 18.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A 2006 4.23
2 Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther 2004 1.80
3 Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance. J Virol 2004 1.39
4 Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005 1.30
5 Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. J Gene Med 2004 1.29
6 Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther 2005 1.21
7 Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII. Mol Ther 2010 1.03
8 In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol Ther 2004 0.99
9 Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One 2010 0.99
10 Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J Gene Med 2005 0.96
11 ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells. Blood 2004 0.88
12 Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Mol Ther 2005 0.81
13 Harnessing autophagy for cell fate control gene therapy. Autophagy 2013 0.81
14 Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection. Mol Cancer Ther 2009 0.80
15 Rapid generation of stable cell lines expressing high levels of erythropoietin, factor VIII, and an antihuman CD20 antibody using lentiviral vectors. Hum Gene Ther Methods 2013 0.76
16 141 Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival. Neurosurgery 2016 0.75
17 Lentiviral vector-mediated genetic modification of cell substrates for the manufacture of proteins and other biologics. PDA J Pharm Sci Technol 2011 0.75
18 Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env. Hum Gene Ther 2007 0.75